Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01043237 · ClinicalTrials.gov registry record

Frequency Analysis of Coronary Artery Disease

A clinical trial of Coronary Artery Disease, sponsored by University of Minnesota.

Completed
Registry status
330
Enrollment target
1
Study location

NCT01043237: Completed study of Coronary Artery Disease, sponsored by University of Minnesota.

NCT01043237 is a study of Coronary Artery Disease that has completed, run by University of Minnesota. The registered enrollment target is 330 participants, below the 1,285-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (74% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01043237, a study of Coronary Artery Disease, has completed, sponsored by University of Minnesota.

COMPLETED
Registry status
330 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine if coronary artery disease can be detected using an electronic, acoustic recording instrument. The presence or absence of abnormal pathology will be confirmed by diagnostic angiography as part of the normal patient care at this institution.

Primary Outcome

to determine if coronary artery disease can be detected using an electronic, acoustic recording instrument

Conditions Studied

Study Locations (1)

Minnesota

  • University of Minnesota Medical Center (UMMC) Fairview Clinics - Minneapolis

Trial Details

FieldValue
Enrollment Target 330 participants
Start Date 2009-03
Est. Completion 2013-03
University of Minnesota

966 total trials

What the finished NCT01043237 record still lists

NCT01043237 is an observational study that tracks outcomes without assigning an intervention. The registered 330 participants enrollment target is mid-sized for trials with a published cap, below the 1,285-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (74% lower).

The record links to 1 condition, with Coronary Artery Disease appearing as the primary indexed condition, and to 0 interventions.

NCT01043237 reports a single indexed study location in Minnesota.

Frequently Asked Questions

What is clinical trial NCT01043237 about?

NCT01043237 is a clinical study titled "Frequency Analysis of Coronary Artery Disease". The purpose of this study is to determine if coronary artery disease can be detected using an electronic, acoustic recording instrument. The presence or absence of abnormal pathology will be confirmed by diagnostic angiography as part of the normal patient care at this institution.

What is the current status of trial NCT01043237?

This trial is currently completed. The enrollment target is 330 participants. The study started on 2009-03. Estimated completion is 2013-03.

What conditions does trial NCT01043237 study?

This clinical trial studies the following conditions: Coronary Artery Disease.

Who is sponsoring clinical trial NCT01043237?

This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01043237 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Coronary Artery Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01043237's enrollment target sits among peer trials

330 99th of 219 higher than 121 of 219 other Coronary Artery Disease trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Coronary Artery Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00359684 · 330 participants

    Use of Cysteamine in the Treatment of Cystinosis

  • NCT03817502 · 330 participants · Phase 3

    Efficacy and Safety of Cariprazine in the Treatment of Adolescent Participants (13 to 17 Years of Age) With Schizophrenia

  • NCT03922724 · 330 participants · Phase 2

    Allogeneic Hematopoietic Cell Transplantation for Peripheral T Cell Lymphoma

  • NCT03932773 · 330 participants · NA

    Multi-site Confirmatory Efficacy Treatment Trial of Combat-related PTSD

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01043237, the US trial registry maintained by the National Library of Medicine. NCT01043237 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.